Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs FAIR LAWN, NJ--(Marketwire - April 14, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the first FDA-approved active transdermal drug delivery system and a leader in active transdermal drug...